782419003: Product containing galcanezumab (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Product containing protein and/or protein derivative (product)\Protein-containing product\Product containing antibody (product)\Product containing monoclonal antibody (product)\Galcanezumab-containing product

\Medicinal product categorized by disposition (product)\Product containing calcitonin gene-related peptide receptor antagonist (product)\Galcanezumab-containing product

\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\Product containing polypeptide (product)\Protein-containing product\Product containing antibody (product)\Product containing monoclonal antibody (product)\Galcanezumab-containing product

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3754005012 Galcanezumab-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3754006013 Product containing galcanezumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3754005012 Galcanezumab-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3754006013 Product containing galcanezumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5589961000241114 produit contenant du galcanézumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

5589961000241114 produit contenant du galcanézumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Galcanezumab-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Galcanezumab (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Galcanezumab-containing product	Is a	Product containing monoclonal antibody (product)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Galcanezumab-containing product	Is a	Product containing calcitonin gene-related peptide receptor antagonist (product)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Galcanezumab-containing product	Is a	Medicinal product acting as antimigraine agent (product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Galcanezumab-containing product	Plays role	Antimigraine therapeutic role	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only galcanezumab (medicinal product)	Is a	True	Galcanezumab-containing product	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing galcanezumab in parenteral dose form (medicinal product form)	Is a	True	Galcanezumab-containing product	Inferred relationship	Existential restriction modifier (core metadata concept)

This concept is not in any reference sets